NCT01852344

Brief Summary

Effortful control refers to the mental processes that help a person to regulate his or her own attention, thoughts, and emotions. This study will examine behavioral differences in healthy individuals when performing a task that induces fatigue. The purpose of this study is to examine the effects of methylphenidate on the cognitive functions in healthy individuals when performing fatiguing cognitive tasks.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
108

participants targeted

Target at P75+ for not_applicable healthy

Timeline
Completed

Started Jun 2012

Longer than P75 for not_applicable healthy

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

June 1, 2012

Completed
11 months until next milestone

First Submitted

Initial submission to the registry

May 1, 2013

Completed
12 days until next milestone

First Posted

Study publicly available on registry

May 13, 2013

Completed
23 days until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 5, 2013

Completed
3.9 years until next milestone

Study Completion

Last participant's last visit for all outcomes

April 24, 2017

Completed
9 months until next milestone

Results Posted

Study results publicly available

January 8, 2018

Completed
Last Updated

January 8, 2018

Status Verified

January 1, 2018

Enrollment Period

1 year

First QC Date

May 1, 2013

Results QC Date

November 29, 2017

Last Update Submit

January 5, 2018

Conditions

Keywords

MethylphenidateEffortful ControlAttention ControlCognitive functions

Outcome Measures

Primary Outcomes (1)

  • Reaction Time on the Multi-Source Interference Task

    Reaction time on the Multi-Source Interference Task is measured in milliseconds. Participants were given 200 trials and their mean reaction time was calculated.

    20-30 minutes for task completion

Secondary Outcomes (2)

  • Accuracy on the Multi-Source Interference Task.

    20-30 minutes

  • Reaction Time Variability on the Multi-Source Interference Task.

    20-30 minutes

Study Arms (4)

Placebo Easy

OTHER

Healthy participant to be given 20 mgs of a placebo one hour before task performance and will perform an easy task.

Drug: PlaceboBehavioral: Easy Behavioral Task

Placebo Hard

OTHER

Healthy participants are given 20 mgs of placebo one hour before task performance and will perform a hard task.

Drug: PlaceboBehavioral: Hard Behavioral Task

Methylphenidate Easy

OTHER

Healthy participants are given 20 mgs of methylphenidate one hour before task performance and will perform an easy task.

Drug: MethylphenidateBehavioral: Easy Behavioral Task

Methylphenidate Hard

OTHER

Healthy participants are given 20 mgs of methylphenidate one hour before task performance and will perform a hard task.

Drug: MethylphenidateBehavioral: Hard Behavioral Task

Interventions

20 mgs of methylphenidate or placebo to be administered one hour before task performance

Also known as: Ritalin
Methylphenidate EasyMethylphenidate Hard

20 mgs of methylphenidate or a placebo to be administered one hour before task performance

Also known as: sugar pill
Placebo EasyPlacebo Hard

Subjects do an easy version of the Letter E Task.

Methylphenidate EasyPlacebo Easy

Subjects do a hard version of the Letter E Task.

Methylphenidate HardPlacebo Hard

Eligibility Criteria

Age18 Years - 35 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • Age range 18-35

You may not qualify if:

  • Pregnant or nursing (females)
  • Any clinically significant medical condition
  • Currently taking any medications (i.e., decongestants)
  • Currently taking any psychoactive medications
  • Alcohol or substance abuse (current or in the past 2 years)
  • Liver or Kidney disease
  • Any clinically significant personal or family history of cardiac problems

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Rachel Upjohn Building, East Medical Campus

Ann Arbor, Michigan, 48109-2700, United States

Location

MeSH Terms

Interventions

MethylphenidateSugars

Intervention Hierarchy (Ancestors)

PhenylacetatesAcids, CarbocyclicCarboxylic AcidsOrganic ChemicalsPiperidinesHeterocyclic Compounds, 1-RingHeterocyclic CompoundsCarbohydrates

Results Point of Contact

Title
Dr. Chandra Sripada, MD PhD
Organization
University of Michigan

Study Officials

  • Chandra Sekhar Sripada, MD, PhD

    University of Michigan

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
Yes

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, INVESTIGATOR
Purpose
BASIC SCIENCE
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Assistant Professor of Psychiatry, Medical School

Study Record Dates

First Submitted

May 1, 2013

First Posted

May 13, 2013

Study Start

June 1, 2012

Primary Completion

June 5, 2013

Study Completion

April 24, 2017

Last Updated

January 8, 2018

Results First Posted

January 8, 2018

Record last verified: 2018-01

Locations